News View All
Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
Location: United States, California, Brisbane
Employees: 11-50
Total raised: $5.7M
Founded date: 2009
Investors 5
| Date | Name | Website |
| - | Health Tec... | hthvc.com |
| 26.10.2023 | SeedFolio | seedfolio.... |
| - | MBC BioLab... | mbcbiolabs... |
| - | Cloudstone... | cloudstone... |
| - | Kairos Ven... | kairosvent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.10.2019 | Grant | $5.7M | - |
Mentions in press and media 5
| Date | Title | Description |
| 13.06.2022 | Kairos Ventures Raises $58 Million to Fund University Spinouts | Kairos Ventures, which bankrolls university scientists and invests in startups emerging from their research, said it has raised $58 million for its latest venture fund. Los Angeles-based Kairos invests in life- and physical-sciences startup... |
| 13.06.2022 | Kairos Ventures Closes Third Fund at $58 Million | Kairos Ventures, a Los Angeles, CA-based early stage venture capital firm investing in physical and life sciences, closed its third fund, at $58M. Fund III has made 27 investments in companies such as: Vivodyne, a bioengineering company cre... |
| 13.06.2022 | Kairos Ventures Gets $58M For Third Fund | Los Angeles-based venture capital investor Kairos Ventures announced today that it has raised $58M for its third fund (Fund III). The investor--which makes investments in companies in the physical and life sciences areas--said that it has a... |
| 19.11.2019 | Science, tech investor Kairos Ventures launches second fundraise of the year, could collect up to $250m | Science and engineering investor Kairos Ventures is looking to raise its biggest fund yet by targeting up to $250m for i |
| - | Kairos Ventures Raises $58M Fund for Early-Stage Life Sciences Startups | Kairos Ventures, a Beverly Hills-based venture capital firm funding early-stage life sciences companies, announced on Monday that it has closed its third fund with $58 million raised. Kairos said its new fund has already invested in 27 star... |